Hyderabad’s Biological E: The dark horse in India’s vaccine race
Biological E has forged multiple deals to co-develop and manufacture Covid-19 vaccines, and is prepared to take on the biggest in the business. It could...
Continue ReadingAurobindo Pharma completes sale of Natrol LLC to New Mountain Capital
Earlier, Aurobindo Pharma Managing Director N Govindarajan had said that proceeds from Natrol’s divestiture will be used to reduce debt and other new strategic initiatives....
Continue ReadingIndian Immunologicals to set up new unit in Telangana
Hyderabad-based biologicals company, Indian Immunologicals Ltd (IIL), announced the ground-breaking of a new viral antigen manufacturing facility in Phase III of Genome Valley, Karkapatla, Ranga...
Continue ReadingPM Modi pushes refrigerated vaccine transport boxes tie up with Luxembourg company in Gujarat
According to official sources based in Delhi and Ahmedabad, Luxembourg firm B Medical Systems is sending a high-level team to Gujarat next week to set...
Continue ReadingVirtual conference on “Supply Chain Challenges of COVID-19 Vaccines: Indian Imperative ”
Click Here to Register
Continue ReadingSingapore startup develops 60-second COVID-19 breathalyzer test
Singapore’s Breathonix has said a clinical trial of its COVID-19 breathalyzer test was able to achieve at least 90% accuracy after screening participants on-site for...
Continue ReadingAmit Srivastava joins Legacy Healthcare India as Board Member
Srivastava will head Legacy Healthcare’s India operations and lead the company’s initiatives from the India office in Bengaluru, with a focus on research to explore...
Continue ReadingTS eyes on $50 bn revenues from life sciences by 2030
Telangana is aiming to achieve $50 billion in cluster revenues (and $100 billion ecosystem valuation) by 2030, and believes that the sector would need to...
Continue ReadingDrugs and vaccines may not swiftly end pandemic, says Merck & Co’s CEO
Merck & Co’s CEO Kenneth Frazier has warned that the drugs and vaccines in the pipeline to combat COVID-19 may not be enough to swiftly...
Continue Reading